HydRegen
PrivateLast Round
Series A
Oct 14, 2026
Total Funding Raised
$15.67M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
HydRegen operates in Energy & Sustainability and is based in Oxford. Its latest recorded funding round was a Series A round in October 2026.
HydRegen is a biotechnology company that develops bio-based manufacturing technologies designed to produce clean, safe, and sustainable chemicals.
Sector
Energy & Sustainability
Verticals
Biotechnology, Clean Manufacturing, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HydRegen Comparables
Compare HydRegen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FabricNano | 87% | |
| Imperagen | 80% | |
| Anodyne Chemistries | 79% |
For institutional investors. Book with your work email.
HydRegen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 14, 2026 | ||||
| Series A | Apr 26, 2023 | ||||
| Seed | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HydRegen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Series A |
| Oxford Science Enterprises | Series A |
| Oxonian Ventures | Series A |
| Genoa Ventures | Series A |
| Innovate UK | Grant |
| First Imagine! | Series A |
| Clean Growth Investment Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2026
Raised $2M in early funding.
- Jun 21, 2026
Monthly visitors increased 444% from 332 to 1.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 16, 2026
HydRegen Limited appoints Pierre Moreau as Process Engineer, Chemistry, strengthening its process development and scale-up capabilities as it advances its biocatalytic technologies toward commercial manufacturing on Oct 16th '26.
- is_developingOct 14, 2026
HydRegen Limited is developing enzyme catalysts that can operate inside existing manufacturing equipment.
- receives_financingOct 14, 2026
On Oct 14th '26 in United Kingdom, HydRegen Limited receives $8M in the first close of its Series A financing led by Genoa Ventures, with participation from Clean Growth Fund and First Imagine! Ventures, to expand customer work and accelerate adoption of its biocatalysis technology.
- hiresOct 13, 2026
HydRegen Limited hires Mark Eldridge as Synthetic Biologist to strengthen its biological capabilities and support the scale-up of its biocatalytic technologies in the United Kingdom on Oct 13th '26.
- hiresOct 7, 2026
HydRegen Limited appoints Kat Usachova as Analytical and DSP Chemist in United Kingdom on Oct 7th '26, strengthening its analytical and downstream processing capabilities as it advances its biocatalytic hydrogenation platform toward commercial deployment.
For institutional investors. Book with your work email.
HydRegen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HydRegen's valuation, stock price, and market status.
Is HydRegen a public or private company?
HydRegen is a private company.
What is the current stock price of HydRegen?
HydRegen is a private company, so its shares have no public market price. Caplight tracks HydRegen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HydRegen worth (valuation)?
Valuation information for HydRegen is not publicly available.
Can I buy HydRegen stock?
HydRegen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HydRegen's last funding round?
HydRegen's most recent funding round was Series A on October 14, 2026.
Who are the main investors in HydRegen?
Key investors in HydRegen include Genoa Ventures, Clean Growth Investment Management, UK Innovation & Science Seed Fund.
Will HydRegen IPO soon?
No public IPO plans have been announced for HydRegen.
How can I track HydRegen secondary market activity?
Caplight tracks bids, offers, and trades in HydRegen's shares on secondary markets.